News | Published:

Novartis snaps up Selexys for sickle cell

Nature Biotechnology volume 35, page 106 (2017) | Download Citation

This article has been updated

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Change history

  • 30 March 2017

    In the version of this article initially published, it was stated that “Modus is developing sevuparin, a P-selectin and E-selectin…” instead of “…a P-selectin and L-selectin…”. The error has been corrected in the HTML and PDF versions of the article.

Author information

Affiliations

  1. Yardley, Pennsylvania

    • Chris Morrison

Authors

  1. Search for Chris Morrison in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0217-106

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing